Abstract
In the reaction between trans-diamminedichloroplatinum(II) and a single-stranded pyrimidin-rich oligodeoxyribonucleotide (22-mer) containing the central sequence TGAGT, the 1,3-trans-[Pt(NH3)2[d(GAG)]] cross-link is formed. The 1,3-intrastrand cross-link is inert within the single-stranded oligonucleotide. In contrast, it rearranges to an interstrand cross-link when the platinated oligonucleotide is paired with its complementary deoxyribo- or ribonucleotide strand. The half-life of the 1,3-intrastrand cross-link, approximately 6 h at 37 degrees C, is independent of the nature and concentration of the salt (NaCl or NaClO4). It is not dramatically affected when the intervening adenine residue between the chelated guanine residues is replaced by a cytosine or a thymine residue or when the T.A base pair adjacent to the 5' or 3' side of the adduct is replaced by a C.G base pair. On the other hand, a mismatch on the 3' or 5' side of the adduct prevents the rearrangement. We propose that the linkage isomerization reaction results from a direct nucleophilic attack of the cytosine residue complementary to the platinated 5' guanine residue on the platinum residue. Among others, the potential use of the DNA.RNA-promoted reaction is discussed in the context of the antisense strategy to irreversibly cross-link the antisense oligonucleotides to their targets.
MeSH Terms
Base Sequence
Cisplatin
Cross-Linking Reagents
DNA/chemistry
Isomerism
Molecular Sequence Data
Nucleic Acid Conformation
Oligodeoxyribonucleotides/chemistry
Oligoribonucleotides/chemistry
Osmolar Concentration
Stereoisomerism
Structure-Activity Relationship
Chemicals
Cross-Linking Reagents
Oligodeoxyribonucleotides
Oligoribonucleotides
transplatin
DNA
Cisplatin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dalbiès R
Centre de Biophysique Moléculaire, Centre National de la Recherche Scientifique, Orleans, France.
Payet D
Leng M
References (23)
23 references, click to expand
-
Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).
Biochemistry. 1983 Aug 2;22(16):3927-33
PMID: 6225458
-
A new method for sequencing DNA.
Proc Natl Acad Sci U S A. 1977 Feb;74(2):560-4
PMID: 265521
-
Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).
Proc Natl Acad Sci U S A. 1985 Jul;82(14):4616-9
PMID: 3895221
-
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA.
Biochemistry. 1986 Jul 1;25(13):3912-5
PMID: 3741840
-
Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione.
Biochemistry. 1987 Jun 16;26(12):3303-7
PMID: 3651385
-
Synthesis and 1H NMR spectroscopic characterization of trans-[Pt(NH3)2[d(ApGpGpCpCpT)-N7-A(1),N7-G(3)]].
Biochemistry. 1987 Sep 8;26(18):5651-7
PMID: 3676275
-
The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes.
Pharmacol Ther. 1987;34(2):155-66
PMID: 3317449
-
Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II).
Chem Biol Interact. 1988;67(1-2):71-80
PMID: 3262435
-
Chemical probes of the conformation of DNA modified by cis-diamminedichloroplatinum(II).
Biochemistry. 1989 Feb 21;28(4):1454-61
PMID: 2719908
-
Identification and characterization of a novel linkage isomerization in the reaction of trans-diamminedichloroplatinum(II) with 5'-d(TCTACGCGTTCT).
Biochemistry. 1990 Feb 27;29(8):2102-10
PMID: 2328242
-
Synthesis and characterization of trans-[Pt(NH3)2Cl2] adducts of d(CCTCGAGTCTCC).d(GGAGACTCGAGG).
Biochemistry. 1990 Jan 23;29(3):811-23
PMID: 2159792
-
Specific regulation of gene expression by antisense, sense and antigene nucleic acids.
Biochim Biophys Acta. 1990 Jun 21;1049(2):99-125
PMID: 1694695
-
Distortions induced in double-stranded oligonucleotides by the binding of cis- or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence.
Nucleic Acids Res. 1990 Aug 11;18(15):4395-400
PMID: 2388824
-
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.
Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1982-5
PMID: 2000402
-
Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.
Proc Natl Acad Sci U S A. 1991 May 1;88(9):3516-9
PMID: 2023897
-
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.
Mol Cell Biol. 1992 Sep;12(9):3689-98
PMID: 1380646
-
Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
Cancer Res. 1992 Sep 15;52(18):5065-72
PMID: 1516063
-
Phosphorodithioate DNA as a potential therapeutic drug.
Science. 1993 Mar 12;259(5101):1564-70
PMID: 7681216
-
A trans-platinum complex showing higher antitumor activity than the cis congeners.
J Med Chem. 1993 Feb 19;36(4):510-2
PMID: 8474104
-
DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5345-9
PMID: 8506383
-
Ligand effects on platinum binding to DNA. A comparison of DNA binding properties for cis- and trans-[PtCl2(amine)2] (amine = NH3, pyridine).
Biochemistry. 1993 Sep 21;32(37):9632-8
PMID: 8373767
-
Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
Nucleic Acids Res. 1993 Dec 25;21(25):5846-51
PMID: 8290343
-
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
Biochemistry. 1985 Jan 29;24(3):707-13
PMID: 4039603